Overview

Study of C1 Inhibitor (Human) for the Prevention of Angioedema Attacks and Treatment of Breakthrough Attacks in Japanese Subjects With Hereditary Angioedema (HAE)

Status:
Completed

Trial end date:
2017-06-23

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine if an investigational treatment is safe and well tolerated when administered by intravenous (IV) infusion in Japanese subjects with HAE.

Phase:

Phase 3

Details

Lead Sponsor:

Shire

Treatments:

Complement C1 Inactivator Proteins
Complement C1 Inhibitor Protein